vTv Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	88.93	36.75	9.45	12.13	13.42
Cash & Short-Term Investments	88.93	36.75	9.45	12.13	13.42
Cash Growth	142.02%	289.01%	-22.10%	-9.61%	133.43%
Accounts Receivable	-	-	0.1	0.17	0.06
Other Current Assets	0.96	1.37	1.11	2.55	2.15
Total Current Assets	89.89	38.11	10.66	27.09	15.62
Net Property, Plant & Equipment	-	-	0.36	0.56	0.68
Long-Term Investments	-	-	-	5.59	9.17
Other Long-Term Assets	0.01	0.15	-	12.24	-
Total Assets	89.9	38.27	11.02	33.24	25.47
Accounts Payable	6.56	5.03	10.24	7.31	8.02
Current Portion of Long-Term Debt	-	-	0.19	0.22	0.26
Current Portion of Leases	-	0.17	0.17	0.15	0.18
Unearned Revenue	18.67	18.67	18.69	18.69	0.04
Other Current Liabilities	0.08	-	-	-	-
Total Current Liabilities	6.64	5.2	10.62	7.71	8.5
Long-Term Leases	-	-	0.17	0.34	0.49
Other Long-Term Liabilities	0.15	0.1	0.11	0.68	1.26
Total Long-Term Liabilities	0.15	0.1	0.28	1.02	1.75
Total Liabilities	25.46	23.97	29.57	27.4	10.25
Common Stock	0.04	0.03	0.03	0.03	0.9
Additional Paid-in Capital	391.09	311.89	256.34	254.76	238.19
Retained Earnings	-326.69	-299.72	-281.04	-265.52	-248.83
Total Common Shareholders' Equity	64.44	12.2	-24.68	-10.74	-9.74
Minority Interest	-	2.1	6.13	16.58	24.96
Shareholders' Equity	64.44	14.3	-18.55	5.84	15.22
Total Liabilities & Equity	89.9	38.27	11.02	33.24	25.47
Total Debt	0	0.17	0.53	0.72	0.93
Net Cash (Debt)	88.93	36.58	8.92	11.41	12.48
Net Cash Growth	143.14%	310.19%	-21.85%	-8.60%	158.34%
Net Cash Per Share	10.56	6.34	4.28	5.94	7.97
Book Value	64.44	12.2	-24.68	-10.74	-9.74
Book Value Per Share	7.65	2.11	-11.84	-5.59	-6.22
Tangible Book Value	64.44	12.2	-24.68	-10.74	-9.74
Tangible Book Value Per Share	7.65	2.11	-11.84	-5.59	-6.22

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q